CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data

Do Young Kim, Hye Jin Kim, Kwang-Hyub Han, Sang Young Han, Jeong Heo, Hyun Young Woo, Soon Ho Um, Yeul Hong Kim, Young Oh Kweon, Ho Yeong Lim, Jung Hwan Yoon, Wan Sik Lee, Byung Seok Lee, Han Chu Lee, Baek-Yeol Ryoo, Seung Kew Yoon

Cancer Research and Treatment. 2016;48(4):1243-1252. Published online 2016 February 24 DOI: https://doi.org/10.4143/crt.2015.278

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data

Cancer Research and Treatment. 2016;48(4):1243-1252

Link1

Link2 Link3

Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience

Masatoshi Kudo, Kazuomi Ueshima, Tadaaki Arizumi

Digestive Diseases. 2012;30(6):609-616

Link1 Link2

Sorafenib for Advanced Hepatocellular Carcinoma: A Real-Life Experience

Larisse Longo, Laura Bainy Rodrigues de Freitas, Deivid Santos, Ivana Grivicich, Mário Reis Álvares-da-Silva

Digestive Diseases. 2018;36(5):377-384

Link1 Link2

P-88 Sorafenib for hepatocellular carcinoma in real life

E. Una Cidon, P. Alonso

Annals of Oncology. 2021;32:S127

Link1 Link2

Global GIDEON data: Subgroup analysis of sorafenib dosing pattern in patients with unresectable hepatocellular carcinoma

Masatoshi Kudo, Sheng-Long Ye, Keiko Nakajima, Riccardo Lencioni

Annals of Oncology. 2016;27:vii90

Link1 Link2 Link3

Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib

Zhonghao Jiang, Chaoliu Dai

Journal of Hepatocellular Carcinoma. 2023;Volume 10:257-266

Link1 Link2

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

Jean-Luc Raoul, Xavier Adhoute, Guillaume Penaranda, Hervé Perrier, Paul Castellani, Valérie Oules, Marc Bourlière

Liver Cancer. 2019;8(6):457-467

Link1 Link2

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

R. Lencioni, J. Marrero, A. Venook, S.-L. Ye, M. Kudo

International Journal of Clinical Practice. 2010;64(8):1034-1041

Link1 Link2

Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea

Diego Novick, Jae Min Cho, Sam Colman, Agota Szende

Drugs - Real World Outcomes. 2021;9(2):263-274

Link1

Link2 Link3

Treatment with sorafenib on hepatocellular carcinoma −10 years’ experience in a nursing-led outpatient clinic

Gordana Grujcic, Pia Loqvist, Hannes Hagström

Journal of Hepatology. 2020;73:S562

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.